Related Experiment Videos

[Molecular dialogue between human retroviruses and host cells]

C A Devaux1

  • 1Laboratoire Infections Rétrovirales et Signalisation Cellulaire CRBM-CNRS UPR1086, Faculté de Médecine, Montpellier. devaux@crbm.cnrs-mop.fr

Insights

Human retroviruses hijack host cells for replication, exploiting cell surface receptors like CD4 and CXCR4. HIV-1 envelope proteins manipulate these interactions to control cell fate, impacting disease progression.

Area of Science:

  • Virology
  • Molecular Biology
  • Immunology

Background:

  • Exogenous retroviruses cause severe human diseases.
  • Retrovirus replication involves complex host-cell interactions and signal transduction pathway subversion.
  • Understanding virus-host molecular crosstalk is crucial for deciphering retroviral physiopathology.

Purpose of the Study:

  • To investigate the molecular mechanisms by which retroviruses interact with host cells.
  • To elucidate how cell surface receptor binding by retroviruses modulates host cell homeostasis.
  • To provide insight into the role of HIV-1 envelope glycoproteins in modulating host cell responses.

Main Methods:

  • Review of recent data on retroviral cell surface receptor utilization.
  • Analysis of molecular cross-talk between retroviruses and host cells.
  • Focus on the function of HIV-1 envelope glycoproteins binding to CD4 and CXCR4.

Main Results:

  • Retroviruses use diverse cell surface receptors to initiate infection.
  • HIV-1 envelope glycoproteins modulate kinase activation and transcription factor nuclear translocation.
  • Binding to CD4 promotes cell activation and proliferation, aiding virus production.
  • Binding to CXCR4 induces apoptosis, diminishing the host immune response.

Conclusions:

  • Retroviruses strategically exploit host cell surface receptors to manipulate cellular processes.
  • HIV-1 envelope glycoproteins play a critical role in viral pathogenesis by altering host cell signaling and survival.
  • Targeting these virus-receptor interactions could offer therapeutic strategies against retroviral infections.

Related Concept Videos